Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2005 (Vol. 25, No. 20)

American Lyme Disease Foundation

URL:www.aldf.com
  • Excellent disease information
  • Site needs inspiration
A few summers ago, the headline–making disease raising concerns in various areas of the U.S. was Lyme Disease. Though today, West Nile Virus has taken over its place in the "spotlight", Lyme Disease is still a serious concern. Spread to humans most commonly by a bite from deer ticks, the causative agent is actually a spirochete bacterium known as Borrelia Burgdorferi. We probably all know the symptoms, starting with a red ring that quickly spreads from the site of the bite. At the ALDF site, you'll learn more about the disease—how it spreads, what Post–Lyme syndrome is, and (good news!) how the disease responds to early treatment. Though it is out of the news right now, the disease is spreading—most recently into Northern California and the Oregon coast. Yikes—that's a little close for me!
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »